The metabolic activation of chemical carcinogens

British Medical Bulletin

Volumn 36, Issue 1, 1980, Pages 11-18

  Sims, Peter ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AFLATOXIN B1; BENZO[A]PYRENE; DIMETHYLNITROSAMINE; N (2 FLUORENYL)ACETAMIDE; NAPHTHALENE; SAFROLE; VINYL CHLORIDE;

CARCINOGENESIS; DRUG METABOLISM; DRUG POTENTIATION; PHARMACOKINETICS; REVIEW;

ANIMAL; BENZOPYRENES; BIOTRANSFORMATION; CARCINOGENS; CYTOCHROME P-450 ENZYME SYSTEM; DNA; EPOXIDE HYDROLASES; EPOXY COMPOUNDS; GLUTATHIONE; HUMAN; LIVER; MICROSOMES, LIVER; NAPHTHALENES; OXYGENASES; RATS; STEREOISOMERISM; SUPPORT, NON-U.S. GOV'T; VINYL CHLORIDE;

EID: 0018845009     PISSN: 00071420     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.bmb.a071607     Document Type: Article

References (95)

1. Alvares A P, Schilling G, Levin W & Kuntzman R (1967) Biochem. Biophys. Res. Commun. 29, 521-526
2. Ames B N, Durston W E, Yamasaki E & Lee F D (1973) Proc. Nall. Acad. Sci. U.S.A. 70, 2281-2285
3. Atlas S A & Nebert D W (1978) Semin. Oncol. 5, 89-106
4. Autrup H (1979) Biochem. Pharmacol. 28, 1727-1730
5. Baird W M, Dipple A, Grover P L, Sims P & Brookes P (1973) Cancer Res. 33, 2386-2392
6. Bartsch H, Traut M & Hecker E (1971) Biochim. Biophys. Acta, 237, 556-566
7. Bartsch H, Malaveille C, Tierney B, Grover PL & Sims P (1979) Chem.-Biol. Interactions, 26, 185-196
8. Bentley P & Oesch F (1975) FEBS Lett. 59, 291-295
9. Booth J & Sims P (1974) FEBS Lett. 47, 30-33
10. Booth J, Keysell G R & Sims P (1973) Biochem. Pharmacol. 22, 1781-1791
11. Borgen A, Darvey H, Castagnoli N, Crocker T T, Rasmussen R E & Wang IY (1973) J. Med. Chem. 16, 502-506
12. Bornstein W A, Chuang H, Bresnick E, Mukhtar H & Bend J R (1978) Chem.-Biol. Interactions, 21, 343-346
13. Boyland E (1950) Biochem. Soc. Symp. no. 5, pp. 40-54
14. Boyland E (1963) The biochemistry of bladder cancer, pp. 41-52. Thomas, Springfield, IL
15. Boyland E & Nery R (1969) Biochem. J. 113, 123-130
16. Bresnick E, Stoming T A, Vaught J B, Thakker D R & Jerina D M (1977) Arch. Biochem. Biophys. 183, 31-37
17. Chasseaud L F (1976) In: Arias I M & Jakob y W B, ed. Ghilathione: metabolism and function, pp. 77-114 (Kroc Foundation Series, vol. 6). Raven Press, New York
18. Chu E H Y & Mailing H V (1968) Proc. Natl. Acad. Sci. U.S.A. 61, 1306-1312
19. Conney A H (1967) Pharmacol. Rev. 19, 317-366
20. Cramer J W, Miller J A & Miller E C (1960) J. Biol. Chem. 235, 885-888
21. Daudel P, Duquesne M, Vigny P, Grover P L & Sims P (1975) FEBS Lett. 57, 250-253
22. Dutton G J (1971) Handb. Exp. Pathol. 28, pt 2, pp. 378-400
23. Estabrook R W, Werringloer J, Capdevila J & Prough R A (1978) In: Gelboin H A & Ts’o P O P, ed. Polycyclic hydrocarbons and cancer. Vol 1: Environment, chemistry and metabolism, pp. 285-319. Academic Press, New York A London
24. Floyd R A, Soong L M, Walker RN & Stuart M (1976) Cancer Res. 36, 2761-2767
25. Glatt H R, Vogel K, Bentley P & Oesch F (1979) Nature (London) 277, 319-320
26. Green T & Hathway D E (1977) Chem.-Biol. Interactions, 17, 137-150
27. Grover P L (1977) In: Parke D V A Smith R L, ed. Drug metabolism-from microbe to man, pp. 105-122. Taylor A Francis, London
28. Grover P L (1979) In: Grover P L, ed. Chemical carcinogens and DNA, vol. 1, pp. 187-226. CRC Press, Boca Raton, FL
29. Grover P L A Sims P (1968) Biochem. J. 110, 159-160
30. Grover P L, Hewer A, Pal K & Sims P (1976) Int. J. Cancer, 18, 1-6
31. Harvey R G & Fu P P (1978) In: Gelboin H V A Ts’o P O P, ed. Polycyclic hydrocarbons and cancer. Vol. 1: Environment, chemistry and metabolism, pp. 133-165. Academic Press, New York & London
32. Hulbert P (1975) Nature (London) 256, 146-148
33. Iball J (1939) Am J. Cancer, 35, 188-190
34. Jakoby W B (1978) Adv. Enzymol. 46, 383-414
35. Jerina DM & Daly J W (1977) In: Parke D V & Smith R L, ed. Drug metabolism-from microbe to man, pp. 13-32. Taylor A Francis, London
36. Jerina DM & Lehr R E (1977) In: Ullrich V, Roots I, Hildebrandt A, Estabrook R W A Conney A H, ed. Microsomes and drug oxidations, pp. 709-720 (Proceedings of the Third International Symposium, Berlin, July 1976). Pergamon, Oxford
37. Kadlubar FF, Miller J A & Miller E C (1976) Cancer Res. 36, 1196-1206
38. Kadlubar F F, Miller J A & Miller E C (1977) Cancer Res. 37, 805-814
39. King C M (1974) Cancer Res. 34, 1503-1515
40. King C M & Phillips B (1968) Science (New York) 159, 1351-1353
41. King C M, Olive C W & Cardona R A (1975) J. Natl. Cancer Inst. 55, 285-287
42. Lawley P D (1976) In: Searie C E, ed. Chemical carcinogens, pp. 83-244 (ACS Monograph 173). American Chemical Society, Washington, DC
43. Lin J K, Miller J A & Miller E C (1968) Biochemistry (Easton) 7, 1889-1895
44. Un J K, Kennan K A, Miller E C & Miller J A (1978) Cancer Res. 38, 2424-2428
45. Lu A Y H, Ryan D, Jerina D M, Daly J W & Levin W (1975) J. Biol Chem. 250, 8283-8288
46. Magee P N, Montesano R A, Preussmann R. (1976) In: Searie C E, ed. Chemical carcinogens, pp. 491-625 (ACS Monograph 173). American Chemical Society, Washington, DC
47. Malaveilie C, Bartsch H, Marquardt H, Baker S, Tierney B, Hewer A, Grover P L A, Sims P (1978) Biochem. Biophys. Res. Commun. 85, 1568-1574
48. Manson D (1976) In: Symington T A Carter R L, ed. Scientific foundations Of oncology, pp. 281-291. Heinemann Medical London
49. Marquardt H (1976) In: Montesano R, Bartsch H A Tomatis L, ed. Screening tests in chemical carcinogenesis, pp. 389-410 (Proceedings of a workshop held in Brussels, Belgium, 9-12 June 1975) (IARC publications no. 12) International Agency for Research on Cancer, Lyon
50. Matsushima T & Sugimura T (1971) Recent Results Cancer Res. 34, 53-60
51. Meehan T & Straub K (1979) Nature (London) 277, 410-412
52. Miller E C & Miller J A (1976) In: Searie C E, ed. Chemical carcinogens, pp. 737-762 (ACS Monograph 173). American Chemical Society, Washington, DC
53. Miller E C, Miller J A & Hartmann H A (1961) Cancer Res. 21, 815-824
54. Miller E C, Lotlikar P D, Miller J A, Butler B W, Irving CC & Hill J T (1968) Mol. Pharmacol. 4, 147-154
55. Montesano R & Bartsch H (1976) Mutat. Res. 32, 179-227
56. Oesch F (1973) Xenobiotica, 3, 305-340
57. Oesch F & Bentley P (1976) Nature (London) 259, 53-55
58. Oesch F & Glatt H R (1976) In: Montesano R, Bartsch H A Tomatis L, ed. Screening tests in chemical carcinogenesis, pp. 255-274 (Proceedings of a workshop held in Brussels, Belgium, 9-12 June 1975). (IARC Scientific publications no. 12). International Agency for Research on Cancer, Lyon
59. Oesch F, Schmassmann H & Bentley P (1978) Biochem. Pharmacol. 27, 1720
60. Pal K, Tierney B, Grover P L & Sims P (1978) Mutat. Res. 50, 367-375
61. Parke D V (1968) The biochemistry of foreign compounds, pp. 34-55. Pergamon, Oxford
62. Perry P & Evans H J (1975) Nature (London) 258, 121-125
63. Phillips D H & Sims P (1979) In: Grover P L, ed. Chemical carcinogens and DNA, vol. 2, pp. 29-58. CRC Press, Boca Raton, FL
64. Phillips D H, Grover P L & Sims P (1978a) Chem.-Biol. Interactions, 20, 63-75
65. Phillips D H, Grover P L & Sims P (1978b) Int. J. Cancer, 22, 487-494
66. Poirier L A, Miller J A, Miller E C & Sato K (1967) Cancer Res. 27, 1600-1613
67. Pullman A & Pullman B (1955) Adv. Cancer Res. 3, 117-169
68. Radomski J L, Conzelman G M Jr, Rey AA & Brill E (1973) J. Natl. Cancer Inst. 50, 989-995
69. Rauckman E J, Rosen G M & Kitchell B B (1979) Mol. Pharmacol. 15, 131-137
70. Rogers K J & Pegg A E (1977) Cancer Res. 37, 4082-4087
71. Roy A B (1971) In: Brodie B B A Gillette J R, ed. Concepts in biochemical pharmacology, pt 2, pp. 536-563. Springer, Berlin
72. Sims P & Grover P L (1974) Adv. Cancer Res. 20, 165-274
73. Sims P, Grover P L, Swaisland A, Pal K & Hewer A (1974) Nature (London) 252, 326-328
74. Slaga T J, Bracken W J, Gleason G, Levin W, Yagi H, Jerina DM & Conney A H (1979) Cancer Res. 39, 67-71
75. Stillwell W G, Carman M J, Bell L & Homing M G (1974) Drug Metab. Disposition, 2, 489-498
76. Styles J A (1977) Br.J. Cancer, 36, 558-563
77. Swenson D H, Lin J K, Miller E C & Miller J A (1977) Cancer Res. 37, 172-181
78. Thakker D R et al. (1978) Mol. Pharmacol. 14, 502-513
79. Thomas P E, Lu A Y H, Ryan D, West S B, Kawalek J & Levin W (1976) Mol. Pharmacol. 12, 746-758
80. Thomas P E, Korzeniowski D, Bresnick E, Bornstein W A, Kasper C B, Fahl W E, Jefcoate C R & Levin W (1919) Arch. Biochem. Biophys. 192, 22-26
81. Thompson M H, Osborne M R, King H W S & Brookes P (1976) Chem.- Biol Interactions, 14, 13-19
82. Tierney B, Hewer A, MacNicoll A D, Gervasi P G, Rattle H, Walsh C, Grover P L & Sims P (1978) Chem.-Biol. Interactions, 23, 243-257
83. Vainio H (1978) Chem.-Biol. Interactions, 22, 117-124
84. Van Cantfort J, Manil L, Gielen J E, Glatt H R & Oesch F (1979) Biochem, Pharmacol. 28, 455-460
85. Wattenberg L W (1978) Adv. Cancer Res. 26, 197-226
86. Weinstein I B, Jeffrey A M, Leffler S, Pulkrabek P, Yamasaki H & Grunberger D (1978) In: Gelboin H V A Ts’o P O P, ed. Polycyclic hydrocarbons and cancer. Vol. 2: Molecular and cell biology, pp. 3-36. Academic Press, New York A London
87. Weisburger J H, Weisburger E K & Morris H P (1961) J. Natl. Cancer Inst. 27, 145-152
88. Wislocki P G, Borchert P, Miller J A & Miller E C (1976) Cancer Res. 36, 1686-1695
89. Wislocki P G, Miller E C, Miller J A, McCoy E C & Rosenkranz H S (1977) Cancer Res. 37, 1883-1891
90. Wood A W, Levin W, Lu A Y H, Yagi H, Hernandez O, Jerina DM & Conney A H (1976) J. Biol. Chem. 251, 4882-4890
91. Wood A W, Chang R L, Levin W, Thomas P E, Ryan D, Stoming T A, Thakker D R, Jerina DM & Conney A H (1978) Cancer Res. 38, 3398-3404
92. Yagi H, Thakker D R, Hernandez O, Koreeda M & Jerina D M (1977) J. Am. Chem. Soc. 99, 1604-1611
93. Yang SK & Gelboin H V (1976) Biochem. Pharmacol 25, 2221-2225
94. Yang S K, Deutsch J & Gelboin H V (1978) In: Gelboin H V & Ts’o POP, ed. Polycyclic hydrocarbons and cancer. Vol. 1: Environment, chemistry and metabolism, pp. 205-231. Academic Press, New York A London
95. Yeh C Y, Fu P P, Beland F A & Harvey R G (1978) Bloorg. Chem. 7, 497-506